Farah Naghashzadeh
Overview
Explore the profile of Farah Naghashzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keshmiri M, Aghdasi S, Noorali S, Shafaghi S, Serati A, Naghashzadeh F, et al.
Int J Angiol
. 2024 Nov;
33(4):307-314.
PMID: 39502345
After the outbreak of the novel coronavirus at the end of December 2019 in China, it has become a global pandemic. Clinical manifestation of coronavirus disease 2019 (COVID-19) has a...
2.
Adimi P, Malekmohammad M, Pourabdollah M, Naghashzadeh F
Tanaffos
. 2024 Apr;
22(3):344-348.
PMID: 38638388
Pulmonary capillary hemangiomatosis (PCH) is a rare cause of pulmonary hypertension. We reported a histologically confirmed PCH in a 42-yr-old lady. She presented a progressive dyspnea and cough after an...
3.
Behzadnia N, Naghashzadeh F, Keshmiri M
Tanaffos
. 2024 Apr;
22(2):268-271.
PMID: 38628885
Background: The coronavirus disease 2019 (COVID-19) has caused a global pandemic with a significant negative impact on health worldwide. Although it primarily involves the respiratory tract system, cardiovascular complications, particularly...
4.
Sharif-Kashani B, Shafaghi S, Naghashzadeh F, Mohamadnia A, Rahdar M, Hajimoradi M, et al.
Tanaffos
. 2023 Aug;
21(4):413-418.
PMID: 37583774
Coronavirus disease 2019 (COVID-19), a highly contagious infectious disease, has had a catastrophic effect on the world's demographics resulting in more than 2.9 million deaths worldwide till January 2021. It...
5.
Serati A, Keshmiri M, Shafaghi S, Mohammad M, Kashani B, Naghashzadeh F, et al.
Crit Pathw Cardiol
. 2023 May;
22(2):60-64.
PMID: 37220659
Background: The coronavirus 2019 (COVID-19) has affected the lives of many people worldwide. Patients with chronic underlying morbidities are vulnerable to get the severe form of the infection. The goal...
6.
Omran H, Naghashzadeh F, Irilouzadian R, Dolatshahi S, Hedayati Goudarzi M, Salehi Omran M
Clin Cardiol
. 2023 Apr;
46(6):674-679.
PMID: 37057368
Background: Patients with nonischemic dilated cardiomyopathy (DCM) are susceptible to arrhythmias and implantable cardioverter defibrillator (ICD) in addition to medical treatments may help prevent sudden cardiac death (SCD) and improve...
7.
Hajimoradi M, Kashani B, Dastan F, Aghdasi S, Abedini A, Naghashzadeh F, et al.
Front Pharmacol
. 2023 Feb;
13:1107198.
PMID: 36733376
Remdesivir is effective against SARS-Cov-2 with little evidence of its adverse effect on the cardiac system. The aim of the present study is investigating the incidence of bradycardia in COVID-19...
8.
Mirenayat M, Abedini A, Kiani A, Eslaminejad A, Adimi Naghan P, Malekmohammad M, et al.
Iran J Pharm Res
. 2022 Jun;
21(1):e123947.
PMID: 35765502
More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried...
9.
Sharif-Kashani B, Serati A, Shafaghi S, Behzadnia N, Naghashzadeh F, Keshmiri M, et al.
Tanaffos
. 2022 Apr;
20(3):287-290.
PMID: 35382080
Pulmonary artery hypertension (PAH) occurs when mean pulmonary artery pressure (PAP) is higher than 25 mmHg in rest or 30 mmHg during activity. Idiopathic pulmonary artery hypertension (IPAH) is defined...
10.
Naghashzadeh F, Shafaghi S, Dorudinia A, Naji S, Marjani M, Amin A, et al.
ESC Heart Fail
. 2022 Feb;
9(2):1483-1486.
PMID: 35106967
SARS-CoV-2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA...